Rocket Pharmaceuticals Ownership | Who Owns Rocket Pharmaceuticals?
Rocket Pharmaceuticals Ownership Summary
Rocket Pharmaceuticals is owned by 42.07% institutional investors, 4.50% insiders, and 53.43% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 15.93% of RCKT shares. Vanguard Health Care Inv is the top mutual fund, with 7.11% of its assets in Rocket Pharmaceuticals shares.
RCKT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rocket Pharmaceuticals | 42.07% | 4.50% | 53.43% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 17.69M | 15.93% | $57.66M |
| Vanguard group | 8.54M | 7.66% | $29.99M |
| Maverick capital | 8.47M | 7.63% | $27.61M |
| Blackrock funding, inc. /de | 7.91M | 7.09% | $27.75M |
| Blackrock | 6.19M | 6.61% | $133.33M |
| Citigroup | 5.25M | 4.70% | $18.41M |
| Janus henderson group | 4.00M | 4.25% | $50.34M |
| Morgan stanley | 3.94M | 3.53% | $13.83M |
| Bioimpact capital | 3.90M | 3.52% | $12.73M |
| Suvretta capital management | 3.84M | 3.46% | $12.53M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 150.71K | 2.53% | $1.89M |
| Bioimpact capital | 3.90M | 2.08% | $12.73M |
| M28 capital management lp | 385.68K | 1.85% | $1.26M |
| Monaco asset management sam | 2.99M | 1.82% | $10.49M |
| Boxer capital | 1.47M | 1.66% | $31.56M |
| Lion point capital, lp | 86.00K | 1.59% | $280.36K |
| Newtyn management | 2.50M | 1.00% | $8.16M |
| Rtw investments, lp | 17.69M | 0.71% | $57.66M |
| Amitell capital pte | 178.77K | 0.70% | $627.48K |
| Cowen and company | 1.10M | 0.65% | $23.68M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Citigroup | 5.25M | 0.01% | 5.24M |
| Janus henderson group | 4.00M | 0.03% | 2.11M |
| Vanguard group | 8.54M | 0.00% | 1.65M |
| Blackrock funding, inc. /de | 7.91M | 0.00% | 791.70K |
| Newtyn management | 2.50M | 1.00% | 502.86K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | - | - | -12.63M |
| Westfield capital management co lp | - | - | -4.82M |
| Point72 asset management | - | - | -1.57M |
| Pictet asset management sa | - | - | -1.32M |
| Avoro capital advisors | - | - | -1.20M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Panagora asset management | 348.80K | 0.00% | 348.80K | $1.22M |
| Hrt financial lp | 109.80K | 0.00% | 109.80K | $385.00K |
| Nebula research & development | 100.78K | 0.02% | 100.78K | $246.91K |
| Lion point capital, lp | 86.00K | 1.59% | 86.00K | $280.36K |
| Man group | 62.58K | 0.00% | 62.58K | $204.00K |
Sold Out
| Holder | Change |
|---|---|
| Wealthspire advisors | -20.00 |
| Allspring global investments | -20.00 |
| Smartleaf asset management | -20.00 |
| First horizon advisors | -24.00 |
| Evermay wealth management | -25.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 114 | -37.36% | 46,937,731 | -51.45% | 42 | 0.55% | 55 | -40.86% | 41 | -31.67% |
| Sep 30, 2025 | 152 | -22.84% | 69,915,346 | -20.60% | 62 | 1.00% | 73 | -38.66% | 55 | 27.91% |
| Jun 30, 2025 | 204 | -17.07% | 94,897,210 | -11.80% | 85 | 0.89% | 123 | -23.13% | 44 | 2.33% |
| Mar 31, 2025 | 246 | 5.58% | 107,782,550 | -1.70% | 97 | 0.72% | 160 | 4.58% | 43 | -6.52% |
| Dec 31, 2024 | 215 | 8.59% | 85,361,633 | -7.77% | 90 | 0.94% | 140 | 44.33% | 43 | -20.37% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 7.60M | 7.11% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.70M | 2.49% | - |
| RTW Biotech Opportunities Ord | 2.57M | 2.37% | 170.76K |
| Vanguard US Total Market Shares ETF | 2.21M | 2.08% | -245.50K |
| iShares Russell 2000 ETF | 2.02M | 1.87% | 1.07M |
| SPDR® S&P Biotech ETF | 1.79M | 1.66% | 10.61K |
| Westfield Capital Mgt Co Sm-Cap Gr Eq | 1.23M | 1.16% | 22.76K |
| Harbor Small Cap Growth Instl | 1.23M | 1.14% | - |
| Vanguard Small Cap Index | 1.05M | 0.97% | 3.90K |
| Vanguard Explorer Inv | 1.02M | 0.94% | 321.37K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Militello John | See Remarks | Sell | $3.86K |
| Feb 18, 2026 | Shah Gaurav | CEO | Sell | $19.99K |
| Feb 18, 2026 | Wilson Martin | General Counsel | Sell | $4.59K |
| Feb 13, 2026 | Wilson Martin | General Counsel | Sell | $40.58K |
| Feb 13, 2026 | Militello John | See Remarks | Sell | $12.34K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 1 | 6 |
| 2025 Q4 | - | 8 |
| 2025 Q3 | 1 | 10 |
| 2025 Q2 | 2 | 12 |
| 2025 Q1 | - | 6 |
RCKT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools